Cardiovascular and diabetes devices are major sources of revenue for the medical device industry. Here, we look at how these two markets are trending across media mentions, earnings calls, and patent applications.
Cardiovascular and diabetes are the most prevalent diseases in the world, and make up two of the largest categories for many medical device companies. While cardiovascular disease has been a bigger market historically for medical device companies, diabetes is becoming more central to these companies’ portfolios.
Below we look at trends in the two markets across our market sizing, media mentions, earnings transcript, and patent analysis tools.
The cardiovascular market is estimated to reach over $59B by 2022 globally.(according to our Market Sizing tool). In comparison, the global diabetes devices market is estimated to reach above $35B by 2024.
As seen in the chart below, public discussions of both markets have stayed relatively similar, with diabetes trending a bit higher in the last 5 years.